MENLO PARK, Calif. , Aug. 03, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2020 . Total revenue for the second quarter of 2020 was $17.1 million , compared with $24.6 million for the same

Joint research effort will lead to molecular assays that can improve variant detection and access difficult-to-sequence regions of the human genome AUSTIN, Texas and MENLO PARK, Calif. , Aug. 03, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California , Inc. (Nasdaq:PACB), a leading provider of

MENLO PARK, Calif. , July 24, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Second Quarter 2020 Financial Results on Monday, August 3, 2020 , at 4:30pm Eastern Time .

Dr. Hunkapiller to retire by the end of 2020 Susan K. Barnes , CFO to retire in August 2020 MENLO PARK, Calif. , June 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today

MENLO PARK, Calif. , June 08, 2020 (GLOBE NEWSWIRE) -- The Board of Directors of Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”) has announced that it is rescheduling the date of the Company’s 2020 Annual Meeting of Stockholders (the “Annual Meeting”) previously scheduled for

MENLO PARK, Calif. , May 06, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2020 . As previously announced, in January 2020 , we and Illumina mutually agreed to terminate the Agreement and Plan

MENLO PARK, Calif. , April 27, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its First Quarter 2020 Financial Results on Wednesday, May 6, 2020 , at 4:30pm Eastern Time .

Deployment expands access to PacBio’s highly accurate long reads on the African continent for a variety of applications, from ethnic-specific reference genomes to COVID-19 research MENLO PARK, Calif. and PRETORIA, South Africa , April 20, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California,

LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related immune response to COVID-19 MENLO PARK, Calif.

MENLO PARK, Calif. , March 18, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not